ClinicalTrials.gov
ClinicalTrials.gov Menu

Dual Time Point PET Imaging in Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00297557
Recruitment Status : Unknown
Verified January 2006 by Royal Marsden NHS Foundation Trust.
Recruitment status was:  Not yet recruiting
First Posted : February 28, 2006
Last Update Posted : October 11, 2006
Sponsor:
Information provided by:
Royal Marsden NHS Foundation Trust

Brief Summary:
Comparison of single time point with dual time point PET imaging in the accuracy of diagnosing active lymphoma. Biopsy results or clinical/radiological progression will be used in conjunction with the PET data.

Condition or disease
Hodgkin's or Non-Hodgkin's Lymphoma

Study Type : Observational
Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lymphoma





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Age 16 and above Diagnosis of Hodgkin's or Non-Hodgkin's lymphoma PET scan scheduled as part of management

Exclusion Criteria:

  • Pregnant or lactating Diabetes mellitus

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00297557


Contacts
Contact: Dr Gary Cook 020 8661 3921

Sponsors and Collaborators
Royal Marsden NHS Foundation Trust
Investigators
Principal Investigator: Dr Gary Cook Royal Marsden NHS Foundation Trust

ClinicalTrials.gov Identifier: NCT00297557     History of Changes
Other Study ID Numbers: CCR2733
First Posted: February 28, 2006    Key Record Dates
Last Update Posted: October 11, 2006
Last Verified: January 2006

Additional relevant MeSH terms:
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases